CONJUNCTIVAL SQUAMOUS-CELL CARCINOMA-ASSOCIATED WITH HIV-INFECTION IN KAMPALA, UGANDA

被引:120
作者
ATEENYIAGABA, C
机构
[1] Department of Ophthalmology, Makerere University Medical School, Kampala
来源
LANCET | 1995年 / 345卷 / 8951期
关键词
D O I
10.1016/S0140-6736(95)90870-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The incidence of conjunctival squamous-cell carcinoma in Kampala, Uganda, was steady at around 6 per million per year from 1970 until 1988, but has increased six-fold since then to 35 per million per year in 1992. Among 48 patients with conjunctival tumours seen at the ophthalmology clinic of the New Mulago Hospital from 1990 to 1991, 75% were HIV seropositive, compared with a 19% seropositivity rate among 48 matched controls (relative risk 13.0, 95% Cl 4.5-39.4, p<0.0001). The recent epidemic of conjunctival tumours in Uganda (and in neighbouring countries) appears to be largely due to the epidemic of HIV infection. Other factors that may contribute to the high incidence of these tumours in equatorial Africa may be exposure to ultraviolet light and conjunctival papillomavirus infection.
引用
收藏
页码:695 / 696
页数:2
相关论文
共 5 条
  • [1] HIV AND CONJUNCTIVAL MALIGNANCIES
    KESTELYN, P
    STEVENS, AM
    NDAYAMBAJE, A
    HANSSENS, M
    VANDEPERRE, P
    [J]. LANCET, 1990, 336 (8706) : 51 - 52
  • [2] NECROTIZING SCLERITIS SECONDARY TO CONJUNCTIVAL SQUAMOUS-CELL CARCINOMA IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    KIM, RY
    SEIFF, SR
    HOWES, EL
    ODONNELL, JJ
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1990, 109 (02) : 231 - 233
  • [3] TEMPLETON A, 1973, RECENT RESULTS CANC, V43, P203
  • [4] BILATERAL CONJUNCTIVAL AND EYELID TUMOR-ASSOCIATED WITH HUMAN PAPILLOMAVIRUS IN AN IMMUNOCOMPETENT MAN
    TRITTEN, JJ
    BEATI, D
    SAHLI, R
    UFFER, S
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1994, 204 (05) : 453 - 455
  • [5] CONJUNCTIVAL SQUAMOUS-CELL CARCINOMA IN A PATIENT WITH HUMAN IMMUNODEFICIENCY VIRUS-INFECTION
    WINWARD, KE
    CURTIN, VT
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1989, 107 (05) : 554 - 555